Natural Dental Implants™ Announces Availability of the REPLICATE™ Non-Surgical Tooth Replacement System in Germany and SwitzerlandMarch 12, 2013 1:00 am | by PR Newswire | News | Comments
BERLIN, March 12, 2013 /PRNewswire-iReach/ -- Berlin-based Natural Dental Implants AG, the developer of the REPLICATE™ Non-Surgical Tooth Replacement System, today announced the availability of the system to customers in Germany and Switzerland. The product will become...
NFL Commissioner Roger Goodell imagines a day in the not-too-distant future when players could be checked to determine whether their genetic makeup leaves them more likely to develop brain disease. They then might be told to switch to a less dangerous position — or give up football entirely.
Technology giant Siemens won FDA clearance to begin distributing the Artis Q and Artis Q.zen angiography systems in the U.S. The technology includes a new X-ray tube with lower radiation levels and updated software for more precise imaging, according to Siemens.
SAN FRANCISCO--(BUSINESS WIRE)--Mar 11, 2013--Alere Inc. (NYSE: ALR) is pleased to announce the results of research presented at today’s American College of Cardiology’s 62nd Annual Scientific Session, which showed that a simple screening and management program can be effective in preventing heart...
Abiomed (NSDQ:ABMD) won expanded reimbursement for its flagship Impella heart pump from 4 private and Medicare Advantage insurers, including 1 of the largest names in the industry. Humana, UnitedHealthcare Medicare Risk, Independence Blue Cross and Capital Blue Cross. The expanded coverage at the private or Medicare Advantage plans includes new Impella policies.
The innovators selected to participate in StartX MedIC were unbelievable individuals. The participants included physicians, surgeons, physicists, electrical engineers, mechanical engineers, computer scientists, data scientists, computer programmers, industrial designers, interface designers, interaction designers, start-up founders, serial entrepreneurs, inventors, PhD students, medical students, and marketing executives from all types organizations and institutions.
The field of transcatheter mitral valve repair may move more quickly in pet populations than it does in human medicine, according to a presentation during this week's American College of Cardiology conference in San Francisco. Researchers are hard at work on a technology, called MitralSeal, they they hope to bring to market to treat mitral valve regurgitation in dogs.
CTIA -The Wireless Association Selects Orthocare Innovations for National Spotlight Featuring Its Cutting-Edge Wireless TechnologyMarch 11, 2013 3:49 pm | by PR Newswire | News | Comments
WASHINGTON, March 11, 2013 /PRNewswire/ -- Orthocare Innovations (www.orthocareinnovations.com) and its Magellan Microprocessor Foot Ankle system are featured in a national multimedia advertising campaign, sponsored by CTIA–The Wireless Association™ (www.ctia.org)....
Omega Honors 30 Companies for Delivering 'World-Class' Customer Service; 3 Cited for Certification in Employee TrainingMarch 11, 2013 1:54 pm | by The Associated Press | News | Comments
The Omega Management Group Corp., specialists in driving companies' revenues and profits by implementing Customer Experience Management (CEM) strategies that increase customer and employee satisfaction, announced today that 30 companies have qualified to receive its NorthFace ScoreBoard...
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that it has elected William H. (Hank) Kucheman to its Board of Directors. Kucheman recently served as interim Chief Executive Officer for Boston Scientific Corporation. During his tenure with Boston Scientific, he held senior business ...
GE, NFL & Leading Healthcare Experts Team up to Accelerate Concussion Research, Diagnosis & TreatmentMarch 11, 2013 1:00 pm | by The Associated Press | News | Comments
NEW YORK--(BUSINESS WIRE)--Mar 11, 2013--(NYSE: GE) – GE and the NFL today announced the Head Health Initiative, a four-year, $60 million collaboration to speed diagnosis and improve treatment for mild traumatic brain injury. The goal of the research and innovation program, guided by healthcare...
With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust AnalysisMarch 11, 2013 12:18 pm | by The Associated Press | News | Comments
Cardiologists at ACC.13 learned today that patients with coronary artery disease who received a Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) as participants in one of several clinical studies and interrupted or discontinued their dual antiplatelet therapy after one month of the implant procedure showed no increased safety risk through one year of follow-up.
CIRTEC Medical Systems, LLC and Core Manufacturing, LLC are pleased to announce that CIRTEC has made a strategic investment that will result in the Company taking a significant equity and controlling board position in Core Manufacturing, LLC; a new entity formed in cooperation with the Alfred Mann Foundation for Scientific Research optimizing its active implantable device manufacturing facility.
The new digitizing probe mounts easily to any Techno CNC plasma machine. The user-friendly TechProbe software will digitize an object with simple or complex geometric shapes.
Murata today announced availability of the Murata Power Solutions PAQ series of 150 Watt isolated DC-DC converters. Packaged as an industry standard open-frame quarter brick module with through-hole mounting, the converter has a 2:1 input range of 36 - 75 VDC around a nominal 48 VDC input.